Skip to main content
Erschienen in: Journal of Neurology 8/2015

01.08.2015 | Original Communication

Neuroimaging evidence of gray and white matter damage and clinical correlates in progressive supranuclear palsy

verfasst von: Maria Cristina Piattella, N. Upadhyay, M. Bologna, E. Sbardella, F. Tona, A. Formica, N. Petsas, A. Berardelli, P. Pantano

Erschienen in: Journal of Neurology | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Abstract

To evaluate gray matter (GM) and white matter (WM) abnormalities and their clinical correlates in patients with progressive supranuclear palsy (PSP). Sixteen PSP patients and sixteen age-matched healthy subjects underwent a clinical evaluation and multimodal magnetic resonance imaging, including three-dimensional T1-weighted imaging and diffusion tensor imaging (DTI). Volumetric and DTI analyses were computed using SPM and FSL tools. PSP patients showed GM volume decrease, involving the frontal cortex, putamen, pallidum, thalamus and accumbens nucleus, cerebellum, and brainstem. Additionally, they had widespread changes in WM bundles, mainly affecting cerebellar peduncles, thalamic radiations, corticospinal tracts, corpus callosum, and longitudinal fasciculi. GM volumes did not correlate with WM abnormalities. DTI indices of WM damage, but not GM volumes, correlated with clinical scores of disease severity and cognitive impairment. The neurodegenerative changes that occur in PSP involve both GM and WM structures and develop concurrently though independently. WM damage in PSP correlates with clinical scores of disease severity and cognitive impairment, thus providing further insight into the pathophysiology of the disease.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10:333–359CrossRefPubMed Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10:333–359CrossRefPubMed
4.
Zurück zum Zitat Boxer AL, Geschwind MD, Belfor N et al (2006) Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 63:81CrossRefPubMed Boxer AL, Geschwind MD, Belfor N et al (2006) Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 63:81CrossRefPubMed
5.
Zurück zum Zitat Ghosh BCP, Calder AJ, Peers PV et al (2012) Social cognitive deficits and their neural correlates in progressive supranuclear palsy. Brain J Neurol 135:2089–2102. doi:10.1093/brain/aws128 CrossRef Ghosh BCP, Calder AJ, Peers PV et al (2012) Social cognitive deficits and their neural correlates in progressive supranuclear palsy. Brain J Neurol 135:2089–2102. doi:10.​1093/​brain/​aws128 CrossRef
7.
Zurück zum Zitat Padovani A, Borroni B, Brambati SM et al (2006) Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 77:457–463PubMedCentralCrossRefPubMed Padovani A, Borroni B, Brambati SM et al (2006) Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 77:457–463PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Price S, Paviour D, Scahill R et al (2004) Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson’s disease. YNIMG Neuroimage 23:663–669CrossRefPubMed Price S, Paviour D, Scahill R et al (2004) Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson’s disease. YNIMG Neuroimage 23:663–669CrossRefPubMed
10.
Zurück zum Zitat Knake S, Belke M, Menzler K et al (2010) In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS. Mov Disord Off J Mov Disord Soc 25:1232–1238. doi:10.1002/mds.23054 CrossRef Knake S, Belke M, Menzler K et al (2010) In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS. Mov Disord Off J Mov Disord Soc 25:1232–1238. doi:10.​1002/​mds.​23054 CrossRef
14.
Zurück zum Zitat Whitwell JL, Avula R, Master A et al (2011) Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Park Relat Disord 17:599–605CrossRef Whitwell JL, Avula R, Master A et al (2011) Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Park Relat Disord 17:599–605CrossRef
15.
Zurück zum Zitat Cordato NJ, Duggins AJ, Halliday GM et al (2005) Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain J Neurol 128:1259–1266. doi:10.1093/brain/awh508 CrossRef Cordato NJ, Duggins AJ, Halliday GM et al (2005) Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain J Neurol 128:1259–1266. doi:10.​1093/​brain/​awh508 CrossRef
17.
Zurück zum Zitat Lee J-H, Han Y-H, Kang B-M et al (2013) Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy. J Neurol. doi:10.1007/s00415-013-6951-x PubMedCentral Lee J-H, Han Y-H, Kang B-M et al (2013) Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy. J Neurol. doi:10.​1007/​s00415-013-6951-x PubMedCentral
18.
Zurück zum Zitat Paviour DC, Price SL, Jahanshahi M et al (2006) Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain J Neurol 129:1040–1049. doi:10.1093/brain/awl021 CrossRef Paviour DC, Price SL, Jahanshahi M et al (2006) Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain J Neurol 129:1040–1049. doi:10.​1093/​brain/​awl021 CrossRef
19.
20.
Zurück zum Zitat Wang J, Wai Y, Lin W-Y et al (2010) Microstructural changes in patients with progressive supranuclear palsy: a diffusion tensor imaging study. J Magn Reson Imaging JMRI 32:69–75. doi:10.1002/jmri.22229 CrossRefPubMed Wang J, Wai Y, Lin W-Y et al (2010) Microstructural changes in patients with progressive supranuclear palsy: a diffusion tensor imaging study. J Magn Reson Imaging JMRI 32:69–75. doi:10.​1002/​jmri.​22229 CrossRefPubMed
22.
Zurück zum Zitat Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9CrossRefPubMed Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9CrossRefPubMed
23.
Zurück zum Zitat Lopez OL, Litvan I, Catt KE et al (1999) Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 53:1292–1299CrossRefPubMed Lopez OL, Litvan I, Catt KE et al (1999) Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 53:1292–1299CrossRefPubMed
24.
Zurück zum Zitat Goetz CG, Fahn S, Martinez-Martin P et al (2007) Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 221:41–47CrossRef Goetz CG, Fahn S, Martinez-Martin P et al (2007) Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 221:41–47CrossRef
26.
Zurück zum Zitat Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 50:318–334CrossRef Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 50:318–334CrossRef
27.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
30.
Zurück zum Zitat Smith SM, Zhang Y, Jenkinson M et al (2002) Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage 17:479–489CrossRefPubMed Smith SM, Zhang Y, Jenkinson M et al (2002) Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage 17:479–489CrossRefPubMed
35.
Zurück zum Zitat Erbetta A, Mandelli ML, Savoiardo M et al (2009) Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration. AJNR Am J Neuroradiol 30:1482–1487. doi:10.3174/ajnr.A1615 CrossRefPubMed Erbetta A, Mandelli ML, Savoiardo M et al (2009) Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration. AJNR Am J Neuroradiol 30:1482–1487. doi:10.​3174/​ajnr.​A1615 CrossRefPubMed
36.
Zurück zum Zitat Agosta F, Kostic VS, Galantucci S et al (2010) The in vivo distribution of brain tissue loss in Richardson’s syndrome and PSP-parkinsonism: a VBM-DARTEL study. Eur J Neurosci 32:640–647CrossRefPubMed Agosta F, Kostic VS, Galantucci S et al (2010) The in vivo distribution of brain tissue loss in Richardson’s syndrome and PSP-parkinsonism: a VBM-DARTEL study. Eur J Neurosci 32:640–647CrossRefPubMed
37.
Zurück zum Zitat Brenneis C, Seppi K, Schocke M et al (2004) Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 75:246–249PubMedCentralPubMed Brenneis C, Seppi K, Schocke M et al (2004) Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 75:246–249PubMedCentralPubMed
38.
Zurück zum Zitat Song S-K, Sun S-W, Ju W-K et al (2003) Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. NeuroImage 20:1714–1722CrossRefPubMed Song S-K, Sun S-W, Ju W-K et al (2003) Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. NeuroImage 20:1714–1722CrossRefPubMed
39.
Zurück zum Zitat Song S-K, Sun S-W, Ramsbottom MJ et al (2002) Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. NeuroImage 17:1429–1436CrossRefPubMed Song S-K, Sun S-W, Ramsbottom MJ et al (2002) Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. NeuroImage 17:1429–1436CrossRefPubMed
41.
Zurück zum Zitat Armstrong RA, Cairns NJ (2013) Spatial patterns of the tau pathology in progressive supranuclear palsy. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 34:337–344. doi:10.1007/s10072-012-1006-0 Armstrong RA, Cairns NJ (2013) Spatial patterns of the tau pathology in progressive supranuclear palsy. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 34:337–344. doi:10.​1007/​s10072-012-1006-0
42.
Zurück zum Zitat Ahmed Z, Asi YT, Lees AJ et al (2013) Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson’s disease. Brain Pathol Zurich Switz 23:263–273. doi:10.1111/j.1750-3639.2012.00637.x CrossRef Ahmed Z, Asi YT, Lees AJ et al (2013) Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson’s disease. Brain Pathol Zurich Switz 23:263–273. doi:10.​1111/​j.​1750-3639.​2012.​00637.​x CrossRef
43.
Metadaten
Titel
Neuroimaging evidence of gray and white matter damage and clinical correlates in progressive supranuclear palsy
verfasst von
Maria Cristina Piattella
N. Upadhyay
M. Bologna
E. Sbardella
F. Tona
A. Formica
N. Petsas
A. Berardelli
P. Pantano
Publikationsdatum
01.08.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 8/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7779-3

Weitere Artikel der Ausgabe 8/2015

Journal of Neurology 8/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.